NCT05769023
A Spatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs
Enrolling by Invitation
NAAges 18+InterventionalPreventionJohns Hopkins Bloomberg School of Public HealthInvestigator-initiated
~40 participants
Updated 2026-05-20 on ClinicalTrials.gov
What's tested:Intervention test
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Vaccine acceptance as assessed by the Oxford COVID-19 Vaccine Hesitancy Scale
Measured over 1 month
Conditions
Where it's being run
1 sites across 1 statesMaryland1
Study leadership
- Carl Latkin, PhD · PRINCIPAL_INVESTIGATOR · Johns Hopkins Bloomberg School of Public Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
opioid use in prior 2 weeks
Exclusion
none
What this trial measures
- Vaccine acceptance as assessed by the Oxford COVID-19 Vaccine Hesitancy Scale1 month
Vaccine acceptance will be assessed using the Oxford COVID-19 Vaccine Hesitancy Scale, a seven-item scale that measures willingness to receive a COVID-19 vaccine. Scores ranged from 7 to 35, with higher scores indicating greater hesitancy.